A Study of Cephalexin in Healthy Participants

NCT02100826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Cephalexin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]